No HPV | Only low risk HPV | One high risk HPV | More than one high risk HPV | Total | |
---|---|---|---|---|---|
N (%) | 64 (11.4) | 134 (23.8) | 183 (32.6) | 181 (32.2) | 562 |
Age in years, median (IQR) | 37.4 (30.3–41.3) | 38.5 (31.1–45.5) | 36.0 (29.9–44.0) | 32.7 (26.5–41.3)a | 35.8 (29.3–43.6) |
Non-white race, n (%) | 50 (79.4) | 99 (73.9) | 129 (71.3) | 124 (68.9) | 402 (72.0) |
Years of formal education, median (IQR) | 8 (5–11) | 8 (5–11) | 8 (5–11) | 9 (6–11)b | 8 (5–11) |
Monthly income (US$), median (IQR) | 400 (255–600) | 425 (250–750) | 400 (232.5–750) | 450 (232.5–800) | 415 (235–750) |
Married/living with partner, n (%) | 34 (53.1) | 85 (63.4) | 100 (54.6) | 102 (56.4) | 321 (57.1) |
Age at sexual debut, median (IQR) | 16 (14–18) | 16 (15–18) | 16 (15–18) | 16 (15–18) | 16 (15–18) |
Number of lifetime sexual partners, median (IQR) | 5 (4–12) | 5 (3–8) | 5 (3–10) | 5 (3–9) | 5 (3–10) |
Condom use with last sexual intercourse, n (%) | 37 (57.8) | 86 (65.7) | 117 (65.4) | 118 (66.3) | 358 (64.9) |
HIV-infected current sexual partner, n (%) | 9 (14.1) | 38 (28.4)c | 28 (15.3) | 50 (27.6)c, d | 125 (22.2) |
Number of pregnancies, median (IQR) | 2 (1–4) | 3 (2–4) | 3 (1–4) | 2 (1–3)a | 2 (1–4) |
Current hormonal contraceptive use, n (%) | 16 (25.0) | 19 (14.3) | 27 (14.8) | 33 (18.2) | 95 (17.0) |
Current tobacco usee, n (%) | 10 (15.6) | 37 (20.6) | 36 (20.2) | 31 (23.1) | 114 (20.5) |
Nadir CD4+ lymphocyte countf, median (IQR) | 302 (190–570) | 307 (155–500) | 255 (128–483) | 256 (90–414)b | 274 (128–467) |
CD4+ lymphocyte count at HPV testg, median (IQR) | 528 (326–827) | 512 (309–679) | 433 (309–631) | 398 (251–549)a, b | 436 (296–679) |
HIV RNA <400 copies/mlh, n (%) | 27 (42.2) | 63 (47.0) | 74 (40.4) | 62 (34.3) | 226 (40.2) |
Total months since cART initiation at HPV test, median (IQR) | 1.65 (0–12.5) | 2.5 (0–15.1) | 3.6 (0–16.9) | 2.0 (0–13.5) | 2.5 (0–14.13) |
Total number of low-risk HPV types detected, median (IQR) | 0 | 1 (1–2) | 1 (1–2) | 2 (1–3)a | 1 (0–2) |
HPV 16 or 18 detected, n (%) | 0 | 0 | 42 (23.0) | 82 (45.3)d | 122 (22.1) |
Cytology results, n (%) | |||||
Any Abnormal | 7 (10.9) | 22 (16.4) | 53 (24.0)c | 84 (46.4)c, d | 166 (29.5) |
ASC-US or AGC | 5 (7.8) | 14 (10.5) | 19 (10.4) | 26 (14.4) | 64 (11.4) |
LSIL | 1 (1.6) | 7 (5.2) | 30 (16.4)c | 47 (26.0)c, d | 85 (15.1) |
HSIL | 1 (1.6) | 1 (0.8) | 4 (2.2) | 10 (5.5) | 16 (2.9) |
Cancer | 0 | 0 | 0 | 1 (0.6) | 1 (0.2) |